Literature DB >> 31886869

Pain Care in the Department of Veterans Affairs: Understanding How a Cultural Shift in Pain Care Impacts Provider Decisions and Collaboration.

Kristin Mattocks1,2, Marc I Rosen3,4, John Sellinger3,4, Tu Ngo5, Brad Brummett1, Diana M Higgins6,7, Thomas E Reznik8,9, Paul Holtzheimer10,11, Alicia M Semiatin12, Todd Stapley13, Steve Martino3,4.   

Abstract

OBJECTIVE: Over the past decade, the Department of Veterans Affairs (VA) has experienced a sizeable shift in its approach to pain. The VA's 2009 Pain Management Directive introduced the Stepped Care Model, which emphasizes an interdisciplinary approach to pain management involving pain referrals and management from primary to specialty care providers. Additionally, the Opioid Safety Initiative and 2017 VA/Department of Defense (DoD) clinical guidelines on opioid prescribing set a new standard for reducing opioid use in the VA. These shifts in pain care have led to new pain management strategies that rely on multidisciplinary teams and nonpharmacologic pain treatments. The goal of this study was to examine how the cultural transformation of pain care has impacted providers, the degree to which VA providers are aware of pain care services at their facilities, and their perceptions of multidisciplinary care and collaboration across VA disciplines.
METHODS: We conducted semistructured phone interviews with 39 VA clinicians in primary care, mental health, pharmacy, and physical therapy/rehabilitation at eight Veterans Integrated Service Network medical centers in New England.
RESULTS: We identified four major themes concerning interdisciplinary pain management approaches: 1) the culture of VA pain care has changed dramatically, with a greater focus on nonpharmacologic approaches to pain, though many "old school" providers continue to prefer medication options; 2) most facilities in this sample have no clear roadmap about which pain treatment pathway to follow, with many providers unaware of what treatment to recommend when; 3) despite multiple options for pain treatment, VA multidisciplinary teams generally work together to ensure that veterans receive coordinated pain care; and 4) veteran preferences for care may not align with existing pain care pathways.
CONCLUSIONS: The VA has shifted its practices regarding pain management, with a greater emphasis on nonpharmacologic pain options. The proliferation of nonpharmacologic pain management strategies requires stakeholders to know how to choose among alternative treatments. 2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  Interdisciplinary Pain Care; Pain Management; Veterans

Mesh:

Substances:

Year:  2020        PMID: 31886869      PMCID: PMC7208326          DOI: 10.1093/pm/pnz341

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  17 in total

1.  Pharmacy Use in the First Year of the Veterans Choice Program: A Mixed-methods Evaluation.

Authors:  Walid F Gellad; Francesca E Cunningham; Chester B Good; Joshua M Thorpe; Carolyn T Thorpe; Brandi Bair; KatieLynn Roman; Susan L Zickmund
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

2.  Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial.

Authors:  Matthew J Bair; Dennis Ang; Jingwei Wu; Samantha D Outcalt; Christy Sargent; Carol Kempf; Amanda Froman; Arlene A Schmid; Teresa M Damush; Zhangsheng Yu; Louanne W Davis; Kurt Kroenke
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

3.  Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans.

Authors:  Lewei A Lin; Amy S B Bohnert; Robert D Kerns; Michael A Clay; Dara Ganoczy; Mark A Ilgen
Journal:  Pain       Date:  2017-05       Impact factor: 6.961

4.  Mindfulness Meditation and Cognitive Behavioral Therapy Intervention Reduces Pain Severity and Sensitivity in Opioid-Treated Chronic Low Back Pain: Pilot Findings from a Randomized Controlled Trial.

Authors:  Aleksandra E Zgierska; Cindy A Burzinski; Jennifer Cox; John Kloke; Aaron Stegner; Dane B Cook; Janice Singles; Shilagh Mirgain; Christopher L Coe; Miroslav Bačkonja
Journal:  Pain Med       Date:  2016-03-10       Impact factor: 3.750

5.  Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.

Authors:  Yuhua Bao; Katherine Wen; Phyllis Johnson; Philip J Jeng; Zachary F Meisel; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2018-10       Impact factor: 6.301

Review 6.  Evidence-informed management of chronic low back pain with spinal manipulation and mobilization.

Authors:  Gert Bronfort; Mitch Haas; Roni Evans; Greg Kawchuk; Simon Dagenais
Journal:  Spine J       Date:  2008 Jan-Feb       Impact factor: 4.166

Review 7.  Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis.

Authors:  Gert Bronfort; Mitchell Haas; Roni L Evans; Lex M Bouter
Journal:  Spine J       Date:  2004 May-Jun       Impact factor: 4.166

8.  Effectiveness of Models Used to Deliver Multimodal Care for Chronic Musculoskeletal Pain: a Rapid Evidence Review.

Authors:  Kim Peterson; Johanna Anderson; Donald Bourne; Katherine Mackey; Mark Helfand
Journal:  J Gen Intern Med       Date:  2018-05       Impact factor: 5.128

Review 9.  Opioid Therapy for Chronic Pain: Overview of the 2017 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline.

Authors:  Jack M Rosenberg; Brandon M Bilka; Sara M Wilson; Christopher Spevak
Journal:  Pain Med       Date:  2018-05-01       Impact factor: 3.750

Review 10.  Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis.

Authors:  Andrew J Vickers; Emily A Vertosick; George Lewith; Hugh MacPherson; Nadine E Foster; Karen J Sherman; Dominik Irnich; Claudia M Witt; Klaus Linde
Journal:  J Pain       Date:  2017-12-02       Impact factor: 5.820

View more
  5 in total

1.  Understanding VA's Use of and Relationships With Community Care Providers Under the MISSION Act.

Authors:  Kristin M Mattocks; Aimee Kroll-Desrosiers; Rebecca Kinney; Anashua R Elwy; Kristin J Cunningham; Michelle A Mengeling
Journal:  Med Care       Date:  2021-06-01       Impact factor: 2.983

2.  Stakeholder Engagement in Pragmatic Clinical Trials: Emphasizing Relationships to Improve Pain Management Delivery and Outcomes.

Authors:  Lori A Bastian; Steven P Cohen; Lily Katsovich; William C Becker; Bradley R Brummett; Diana J Burgess; Andrea E Crunkhorn; Lauren M Denneson; Joseph W Frank; Christine Goertz; Brian Ilfeld; Kathryn E Kanzler; Akshaya Krishnaswamy; Kathryn LaChappelle; Steve Martino; Kristin Mattocks; Cindy A McGeary; Thomas E Reznik; Daniel I Rhon; Stacie A Salsbury; Karen H Seal; Alicia M Semiatin; Marlena H Shin; Corey B Simon; Deydre S Teyhen; Kara Zamora; Robert D Kerns
Journal:  Pain Med       Date:  2020-12-12       Impact factor: 3.637

3.  Improving Veteran Access to Integrated Management of Back Pain (AIM-Back): Protocol for an Embedded Pragmatic Cluster-Randomized Trial.

Authors:  Steven Z George; Cynthia J Coffman; Kelli D Allen; Trevor A Lentz; Ashley Choate; Adam P Goode; Corey B Simon; Janet M Grubber; Heather King; Chad E Cook; Francis J Keefe; Lindsay A Ballengee; Jennifer Naylor; Joseph Leo Brothers; Catherine Stanwyck; Aviel Alkon; Susan N Hastings
Journal:  Pain Med       Date:  2020-12-12       Impact factor: 3.750

4.  Justice and equity in pragmatic clinical trials: Considerations for pain research within integrated health systems.

Authors:  Joseph Ali; Alison F Davis; Diana J Burgess; Daniel I Rhon; Robert Vining; Stacey Young-McCaughan; Sean Green; Robert D Kerns
Journal:  Learn Health Syst       Date:  2021-10-19

Review 5.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.